Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.94−0.07 (-2.33%)
Close on Nov 13, 2026Market cap $118.70MP/E –Yield –
Molecular Partners market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Molecular Partners's market cap was $115.17M on Nov 11, 2026, against $140.27M a year earlier. Over the last 5 years it ranged from $115.17M to $797.17M, with a median of $169.57M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $115.17M | -22.4% |
| 2025 | Dec 31, 2025 | $148.33M | -4.7% |
| 2024 | Dec 31, 2024 | $155.60M | +11.9% |
| 2023 | Dec 29, 2023 | $139.05M | -31.5% |
| 2022 | Dec 30, 2022 | $203.08M | -63.7% |
| 2021 | Dec 31, 2021 | $559.04M | – |
See a number that looks wrong?